Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Mobutazon

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Mobutazon

EINECS 218-641-1
CAS No. 2210-63-1 Density 1.14g/cm3
PSA 49.41000 LogP 2.26460
Solubility DMSO (Slightly), Methanol (Slightly) Melting Point 102-104°C
Formula C13H16 N2 O2 Boiling Point °Cat760mmHg
Molecular Weight 232.282 Flash Point °C
Transport Information N/A Appearance N/A
Safety Moderately toxic by intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx. Risk Codes N/A
Molecular Structure Molecular Structure of 2210-63-1 (MOFEBUTAZONE) Hazard Symbols N/A
Synonyms

1-Phenyl-4-butyl-3,5-pyrazolidinedione;1-Phenyl-4-butylpyrazolidin-3,5-dione;1-Phenyl-4-n-butyl-3,5-dioxopyrazolidine;2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine;4-Butyl-1-phenyl-3,5-dioxopyrazolidine;4-Butyl-1-phenyl-3,5-pyrazolidinedione;4-Butyl-3,5-dioxo-1-phenyltetrahydropyrazole;Arcobutine;Arcomonol Tablets;Butazone;Mobutazon;Mobutazone;Mobuzon;Mofebutazone;Mofesal;Monazan;Monazon;Monobutyl;Monofen;Monofenew;Monomil;Monophenylbutazone;Monorheumetten;Monozon;Mophebutazone;Mozol;NSC 73725;Reumatox;

 

Mobutazon Chemical Properties

Chemistry informtion about Mobutazon (CAS NO.2210-63-1) is:
IUPAC Name: 4-Butyl-1-Phenylpyrazolidine-3,5-Dione
Synonyms: Mofebutazone ; 2fdbp ; 2-Phenyl-3,5-Dihydroxy-4-Butylpyrazolidine ; 4-Butyl-1-Phenyl-3,5-Dioxopyrazolidine ; 4-Butyl-1-Phenyl-3,5-Pyrazolidinedione ; 4-Butyl-1-Phenyl-5-Pyrazolidinedione ; Arcomonoltablets ; Mobutazon
MF: C13H16N2O2
MW: 232.28
EINECS: 218-641-1 
Density: 1.14 g/cm3
Following is the molecular structure of Mobutazon (CAS NO.2210-63-1) is:

Mobutazon Uses

 Mobutazon (CAS NO.2210-63-1) is a drug used for joint and muscular pain.

Mobutazon Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 700mg/kg (700mg/kg) behavioral: tremor behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea Scientia Pharmaceutica. Vol. 37, Pg. 185, 1969.
mouse LD50 intravenous 600mg/kg (600mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 233, Pg. 365, 1958.
mouse LD50 subcutaneous 920mg/kg (920mg/kg) behavioral: tremor lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold Scientia Pharmaceutica. Vol. 37, Pg. 185, 1969.
rat LD50 intraperitoneal 848mg/kg (848mg/kg)   Farmaco, Edizione Scientifica. Vol. 14, Pg. 347, 1959.
rat LD50 oral 1750mg/kg (1750mg/kg)   Pharmaceutica Acta Helvetiae. Vol. 39, Pg. 155, 1964.

Mobutazon Safety Profile

Moderately toxic by intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx.

Mobutazon Specification

 

Mofebutazone is an anti-inflammatory drug used on the gastrointestinal and renal tissues.


 

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2210-63-1